Área Sanitaria de Santiago de Compostela e Barbanza
Área sanitaria
Hospital Sierrallana
Torrelavega, EspañaPublicacións en colaboración con investigadores/as de Hospital Sierrallana (23)
2024
-
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort
Lupus Science and Medicine, Vol. 11, Núm. 1
2023
-
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry
The European respiratory journal
-
Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)
Respiratory Research
-
Epidemiology and clinical domains of Behçet's disease in the Cantabria region, Northern Spain
Clinical and experimental rheumatology, Vol. 41, Núm. 10, pp. 1991-1997
-
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
-
Systemic treatment in sarcoidosis: Experience over two decades
European Journal of Internal Medicine, Vol. 108, pp. 60-67
-
Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review
RMD open, Vol. 9, Núm. 1
2022
-
Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
Respiratory Research, Vol. 23, Núm. 1
-
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
Therapeutic Advances in Musculoskeletal Disease, Vol. 14
2021
-
Efficacy and safety of intermittent repeated levosimendan infusions in advanced heart failure patients: the LAICA study
ESC Heart Failure, Vol. 8, Núm. 6, pp. 4820-4831
-
Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
Frontiers in Medicine, Vol. 8
-
Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients
Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 2, pp. 387-394
-
Treatment with tofacitinib in refractory psoriatic arthritis: A national multicenter study of the first 87 patients in clinical practice
Journal of Rheumatology, Vol. 48, Núm. 10, pp. 1552-1558
2020
-
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
-
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135
2018
-
Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations
Journal of Medical Genetics, Vol. 55, Núm. 12, pp. 814-823
2017
-
Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort
Arthritis Care and Research, Vol. 69, Núm. 6, pp. 938-942
2015
-
Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients
Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 717-723